Hanall Biopharma Co Ltd 009420
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₩37,400.00
- Day Range
- ₩37,450.00–39,300.00
- 52-Week Range
- ₩28,500.00–46,750.00
- Bid/Ask
- ₩37,400.00 / ₩39,000.00
- Market Cap
- ₩1.98 Tril
- Volume/Avg
- 529,472 / 647,937
Key Statistics
- Price/Earnings (Normalized)
- 374.30
- Price/Sales
- 15.17
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Hanall Biopharma Co Ltd is a part of the healthcare sector. It is one of Korea's leading pharmaceutical companies and is focused on drug delivery, biotherapeutics, and new small molecule discovery. The company's scope comprises of ophthalmology, immunology, cardiovascular treatment and dermatology.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 320
- Website
- http://www.hanall.co.kr
Comparables
Valuation
|
Metric
|
009420
|
039200
|
005500
|
|---|---|---|---|
Price/Earnings (Normalized) | 374.30 | — | 6.26 |
Price/Book Value | 12.02 | 16.71 | 0.83 |
Price/Sales | 15.17 | 315.84 | 0.81 |
Price/Cash Flow | — | — | 3.63 |
Price/Earnings
009420
039200
005500
Financial Strength
|
Metric
|
009420
|
039200
|
005500
|
|---|---|---|---|
Quick Ratio | 2.00 | 2.29 | 0.43 |
Current Ratio | 3.14 | 2.37 | 1.00 |
Interest Coverage | −118.68 | −131.58 | 9.65 |
Quick Ratio
009420
039200
005500
Profitability
|
Metric
|
009420
|
039200
|
005500
|
|---|---|---|---|
Return on Assets (Normalized) | −1.76% | −24.13% | 9.14% |
Return on Equity (Normalized) | −2.31% | −31.91% | 14.45% |
Return on Invested Capital (Normalized) | −2.61% | −34.10% | 11.25% |
Return on Assets
009420
039200
005500
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Rpnzbnmtc | Rvkt | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Vfcrsqdqtp | Jrkssjd | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Rtkfsfwq | Fggb | $45.9 Bil | |||
| Viatris Inc
VTRS
| Pzqnxgcn | Ckmj | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Jyshjtsd | Mxml | $13.2 Bil | |||
| Catalent Inc
CTLT
| Mzhbmtb | Snptpj | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Zcqgsdqq | Qggnvn | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Pclzrzgv | Ntrps | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Fttkcngzzw | Mbc | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Svbvrny | Cbyc | $2.2 Bil |
United States